Compound: STANOLONE
SMILES: O=C1C[C@H]2[C@]([C@@H]3[C@H]([C@H]4[C@]([C@@H](O)CC4)(C)CC3)CC2)(C)CC1
InChIKey: NVKAWKQGWWIWPM-ABEVXSGRSA-N
Synonyms: STANOLONE, Androstanolone, dihydrotestosterone, 521-18-6, Anabolex, Andractim, Androlone, Neodrol, 4-Dihydrotestosterone, Anaboleen, Proteina, Stanaprol, Protona, Cristerona MB, 17beta-Hydroxy-5alpha-androstan-3-one, 5alpha-Dihydrotestosterone, Androstanolona, 5alpha-Androstan-17beta-ol-3-one, 5-alpha-Dihydrotestosterone, Testosterone, dihydro-, 4,5alpha-Dihydrotestosterone, Androstanolonum, 5alpha-DHT, Androstalone, Dihydrotestosteron, 17beta-Hydroxy-3-androstanone, dihydrotestosterone (dht), Androstan-17beta-ol-3-one, 5alpha,17beta-Hydroxyandrostan-3-one, NSC-10972, DTXSID9022364, CHEBI:16330, 08J2K08A3Y, Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-, 17beta-Hydroxy-5alpha-androstane-3-one, DTXCID202364, (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one, (5alpha,17beta)-17-hydroxyandrostan-3-one, NSC10972, (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta(a)phenanthren-3-one, 17 beta Hydroxy 5 beta Androstan 3 One, 5 alpha DHT, 5-alpha-DHT, RefChem:587772, 5 beta Dihydrotestosterone, 5 alpha Dihydrotestosterone, 5 alpha-Dihydrotestosterone, 5-alpha Dihydrotestosterone, Dihydrotestosterone, 5-alpha, THERAPEUTIC ANDROSTANOLONE, A14AA01, G03BB02, LG152, 17beta Hydroxy 5alpha Androstan 3 One, beta-Hydroxy-5 beta-Androstan-3-One, 17, (1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadecan-5-one, 208-307-3, DHT, Stanorone, NSC 10972, 5a-Dihydrotestosterone, Androstanolone [INN], 17-beta-Hydroxy-5-alpha-androstan-3-one, 5alpha-dihydrotesosterone, 5alpha dihydrotestosterone, 5.alpha.-Dihydrotestosterone, 5alpha-Androstan-3-one, 17beta-hydroxy-, CHEMBL27769, 4,5.alpha.-Dihydrotestosterone, 17beta-Hydroxy-androstan-3-one, 5-alpha-Androstan-3-one, 17-beta-hydroxy-, 17.beta.-Hydroxy-3-androstanone, (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyltetradecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, Androstanolone (INN), 5.alpha.-Androstan-17.beta.-ol-3-one, NCGC00091013-01, Stanolon, 5.alpha.,17.beta.-Hydroxyandrostan-3-one, [3H]DHT, BDBM50366473, 5alpha-Dihydroxytestosterone, Androstanolone (1mg/ml in Acetonitrile), Androstanolonum [INN-Latin], (1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one, CAS-521-18-6, Androstanolona [INN-Spanish], 4,5-alpha-Dihydrotestosterone, 5-.alpha.-Androstanolone, Androstanolone (1.0 mg/mL in Acetonitrile), 5.alpha.-Androstan-3-one, 17.beta.-hydroxy-, [3H]dihydrotestosterone, [3H]-dihydrotestosterone, EINECS 208-307-3, 5alpha,17eta-Hydroxyandrostan-3-one, Androstan-17.beta.-ol-3-one, 5-alpha-Androstan-17-beta-ol-3-one, 17-beta-hydroxyandrostan-3-one, Androstan-3-one, 17-hydroxy-, (5.alpha.,17.beta.)-, Andrin, UNII-08J2K08A3Y, (+)-Androstan-17.beta.-ol-3-one, 521-18-6 (free), 1kdk, 2ama, Androstan-3-one, 17-hydroxy-, (5a,17b)-, (5-alpha,17-beta)-17-Hydroxyandrostan-3-one, Andractim (TN), 5-a-Androstanolone, 5alpha-Androstanolone, Androstanolone (DHT), 17-.beta.-Hydroxy-5-.alpha.-androstan-3-one, 5-alpha-Androstanolone, 1d2s, 1t5z, 1t7r, STANOLONE [MI], (5.alpha.,17.beta.)-17-Hydroxy-androstan-3-one, 4,5a-Dihydrotestosterone, Androstan-17b-ol-3-one, Epitope ID:135868, 17-Hydroxyandrostan-3-one, (5.alpha.,17.beta.)- #, EC 208-307-3, 17b-Hydroxy-3-androstanone, BIDD:PXR0075, SCHEMBL15163, 17-Hydroxy-androstan-3-one, MLS001304063, 5a-Androstan-17b-ol-3-one, BIDD:ER0136, 5.alpha.-Dihydroxytestosterone, 5A-Androstan-3-on-17B-ol, 5B-Androstan-3-on-17B-ol, ANDROSTANOLONE [MART.], GTPL2856, GTPL3455, orb2647466, ANDROSTANOLONE [WHO-DD], BDBM18161, 1t63, (+)-Androstan-17beta-ol-3-one, HMS2272H05, 5alpha-Dihydrotestosterone  degrees, HY-A0120, Tox21_111056, Tox21_200987, Tox21_303655, LMST02020042, MSK8502-100A, s4757, AKOS015894892, CCG-267385, CS-5096, DB02901, FA17912, GS-6587, (5a,17b)-17-Hydroxyandrostan-3-one, NCGC00091013-02, NCGC00091013-03, NCGC00257456-01, NCGC00258540-01, (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one, 17beta-hydroxy-3-oxo-5alpha-androstanone, AC-16144, AC-33095, SMR000058342, NS00005234, TESTOSTERONE IMPURITY F [EP IMPURITY], 5alpha-Androstan-17beta-ol-3-one, >=97.5%, C03917, D07456, Dihydrotestosterone; Testosterone EP Impurity F, 5Alpha-Dihydrotestosterone, 1mg/ml in Acetonitrile, Q411054, 17.BETA.-HYDROXY-5.ALPHA.-ANDROSTAN-3-ONE, 17.BETA.-HYDROXY-5.ALPHA.-ANDROSTANE-3-ONE, Androstanolone (5alpha-Dihydrotestosterone, Stanolone), BRD-K22525962-001-05-0, Dihydrotestosterone Solution in Acetonitrile, 100ug/mL, 5alpha-Androstan-17beta-ol-3-one, purum, >=99.0% (TLC), 5alpha-Androstan-17beta-ol-3-one, VETRANAL(TM), analytical standard, Androstanolone (5alpha-Dihydrotestosterone, Stanolone) 1.0 mg/ml in Acetonitrile, (5S,8R,10S,13S,17S)-17-Hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one, 17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,10,11,12,13,14,15,16, 17-hexadecahydrocyclopenta[a]phenanthren-3-one
Theoretical properties:
molecular_formula: C19H30O2
molecular_weight: 290.4 g/mol
exact_mass: 290.224580195 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 1
hydrogen_bond_acceptor_count: 2
rotatable_bond_count: 0
heavy_atom_count: 21
topological_polar_surface_area: 37.3 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
{"pubchem": "17beta-hydroxy-5alpha-androstan-3-one is a 17beta-hydroxy steroid that is testosterone in which the 4,5 double bond has been reduced to a single bond with alpha-configuration at position 5. It has a role as an androgen, a mouse metabolite, a human metabolite and a Daphnia magna metabolite. It is a 3-oxo-5alpha-steroid, a 17beta-hydroxy steroid and a 17beta-hydroxyandrostan-3-one. It derives from a hydride of a 5alpha-androstane.", "chebi": "A 17\u03b2-hydroxy steroid that is testosterone in which the 4,5 double bond has been reduced to a single bond with \u03b1-configuration at position 5.", "chembl": "STANOLONE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 2.0.", "wikipedia": "Androstanolone, or stanolone, also known as dihydrotestosterone (DHT) and sold under the brand name Andractim among others, is an androgen and anabolic steroid (AAS) medication and hormone which is used mainly in the treatment of low testosterone levels in men. It is also used to treat breast development and small penis in males. \nCompared to testosterone, androstanolone (DHT) is less likely to aromatize into estrogen, and therefore it shows less pronounced estrogenic side effects, such as gynecomastia and water retention. On the other hand, androstanolone (DHT) show more significant androgenic side effects, such as acne, hair loss and prostate enlargement. \nIt has strong androgenic effects and  muscle-building effects, as well as relatively weak estrogenic effects.\nIt is typically given as a gel for application to the skin, but can also be used as an ester by injection into muscle.\nSide effects of androstanolone include symptoms of masculinization like acne, increased hair growth, voice changes, and increased sexual desire. The medication is a naturally occurring androgen and anabolic steroid and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and DHT. \nAndrostanolone was discovered in 1935 and was introduced for medical use in 1953. It is used mostly in France and Belgium. The drug has been used by weightlifters to increase performance due to its powerful androgenic properties. The medication is a controlled substance in many countries and so non-medical use is generally not permitted."}